Perrigo talks $500 million 10-year notes for pricing Thursday

By Andrea Heisinger

New York, May 9 - Perrigo Co. is planning a $500 million sale of 10-year notes for Thursday's session, according to a market source and a 424B3 filing with the Securities and Exchange Commission.

Initial guidance is in the 140 basis points area over Treasuries, the source said, adding that the company does not have any outstanding bonds.

The bonds feature a change-of-control put at 101%.

Active bookrunners are BofA Merrill Lynch, Morgan Stanley & Co. LLC and Wells Fargo Securities LLC. The passive bookrunner is J.P. Morgan Securities LLC.

Proceeds will be used for general corporate purposes.

The health care company and maker of generic and over-the-counter pharmaceuticals is based in Allegan, Mich.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.